515 related articles for article (PubMed ID: 23721823)
1. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
2. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.
Moreb JS; Ucar-Bilyeu DA; Khan A
Cancer Chemother Pharmacol; 2017 Feb; 79(2):295-301. PubMed ID: 27942929
[TBL] [Abstract][Full Text] [Related]
3. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
4. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
Zhang G; Ma L; Xie YK; Miao XB; Jin C
Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
[TBL] [Abstract][Full Text] [Related]
5. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
[TBL] [Abstract][Full Text] [Related]
6. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
7. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
8. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
Zhang S; Yang Z; Qi F
Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
[TBL] [Abstract][Full Text] [Related]
11. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Cojoc M; Mäbert K; Muders MH; Dubrovska A
Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
[TBL] [Abstract][Full Text] [Related]
12. ALDH as a Stem Cell Marker in Solid Tumors.
Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
[TBL] [Abstract][Full Text] [Related]
13. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenases and cancer stem cells.
Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
[TBL] [Abstract][Full Text] [Related]
16. Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells.
Al-Shamma SA; Zaher DM; Hersi F; Abu Jayab NN; Omar HA
Life Sci; 2023 May; 320():121541. PubMed ID: 36870386
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
18. Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells.
Kim SK; Kim H; Lee DH; Kim TS; Kim T; Chung C; Koh GY; Kim H; Lim DS
PLoS One; 2013; 8(10):e78130. PubMed ID: 24194908
[TBL] [Abstract][Full Text] [Related]
19. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]